Larvol Delta - Adjuvant-CDK46-inhibitors-in-earlystage-breast-cancer-Clinical-evidence-and-considerations-for-risk-stratification-and-treatment-selection

Kisqali (ribociclib) - Novartis

Ibrance (palbociclib) - Pfizer

Verzenio (abemaciclib) - Eli Lilly

http://www.ncbi.nlm.nih.gov/pubmed/42667265

Anna Weiss; Austin D Williams

Aug 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next